Preclinical studies of antiviral activity of the RPH-137 fusion protein and molnupiravir against COVID-19 von Shipaeva, E. V., Filon, O. V., Zintchenko, A. V., Shipunov, G. A., Dmitrieva, A. A., Lemak, M. S., Grishin, S. A., Trofimets, E. I., Kryshen, K. L., Kozlovskaya, L. I., Lunin, A. S., Apolokhov, V. D., Barbashov, S. F., Lavrovsky, Ya. V., Samsonov, M. Yu

Volltext

Inactivated whole virion vaccine protects K18‐hACE2 Tg mice against the Omicron SARS‐CoV‐2 variant via cross‐reactive T cells and nonneutralizing antibody responses von Kruglov, Andrey A., Bondareva, Marina A., Gogoleva, Violetta S., Semin, Iaroslav K., Astrakhantseva, Irina V., Zvartsev, Ruslan, Lunin, Aleksandr S., Apolokhov, Vasiliy D., Shustova, Elena Yu, Volok, Viktor P., Ustyugov, Aleksey A., Ishmukhametov, Aydar A., Nedospasov, Sergei A., Kozlovskaya, Liubov I., Drutskaya, Marina S.

Volltext